Eliel Bayever,Sarah F. Blanchette,Jonathan Basil Fitzgerald,Daniel F. Gaddy,Bart S. Hendriks,Ashish Kalra,Helen Lee
申请号：
US15241106
公开号：
US20170049775A1
申请日:
2016.08.19
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of pancreatic cancer, including treatment of patients diagnosed with previously untreated metastatic adenocarcinoma of the pancreas. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.
